Test ID: GRHMS
GRHPR Gene, Full Gene Analysis
NY State Approved
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For
Suggests clinical disorders or settings where the test may be helpful
Confirming a diagnosis of primary hyperoxaluria type 2 (PH2)
Carrier testing for individuals with a family history of PH2 in the absence of known mutations in the family
Special Instructions and Forms
Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name
A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) followed by DNA Sequence Analysis and Gene Dosage Analysis by Multiplex Ligation-Dependent Probe Amplification (MLPA)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
GRHPR Gene, Full Gene Analysis
Aliases
Lists additional common names for a test, as an aid in searching
Primary Hyperoxaluria
Primary Hyperoxaluria Type 2 (PH2)
Primary Hyperoxaluria Type II
Hyperoxaluria
PH2 (Primary Hyperoxaluria Type 2)
GR/HPR
Glyoxylate reductase/hydroxypyruvate reductase
Primary Hyperoxaluria Type 2 (PH2)
Primary Hyperoxaluria Type II
Hyperoxaluria
PH2 (Primary Hyperoxaluria Type 2)
GR/HPR
Glyoxylate reductase/hydroxypyruvate reductase


